Skip to main content

Table 3 Comparison between the non-insulin group before and after treatment (n = 22)

From: Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Parameter

Before

After

BMI (kg/m2) n = 19

23.2 ± 1.0

23.3 ± 1.0

Systolic blood pressure (mmHg) n = 20

155.7 ± 6.3

162.3 ± 5.4

Diastolic blood pressure (mmHg) n = 20

78.7 ± 3.3

79.7 ± 3.0

Total protein (g/dL)

6.5 ± 0.1

6.6 ± 0.1

Albumin (g/dL)

3.7 ± 0.1

3.8 ± 0.1

AST (U/L)

14.9 ± 1.0

13.4 ± 1.2

ALT (U/L) n = 21

11.6 ± 1.4

10.1 ± 1.6

γ1.6 (U/L)

22.3 ± 3.0

23.2 ± 3.4

Total bilirubin (mg/dL) n = 17

0.35 ± 0.03

0.28 ± 0.02*

ALP (U/L) n = 21

251.0 ± 28.4

256.7 ± 25.8

LDH (U/L) n = 21

189.5 ± 6.0

179.2 ± 6.1

BUN (mg/dL)

54.5 ± 1.8

53.8 ± 2.3

Creatinine (mg/dL)

8.21 ± 0.34

8.28 ± 0.44

Total cholesterol (mg/dL)

162.6 ± 8.2

149.6 ± 6.9*

LDL-C (mg/dL) n = 21

83.1 ± 5.9

75.8 ± 5.0*

HDL-C (mg/dL)

46.9 ± 3.4

47.5 ± 3.5

Triglyceride (mg/dL) n = 21

119.7 ± 9.4

121.2 ± 11.9

CPR (ng/mL) n = 19

10.62 ± 1.20

11.56 ± 1.32

BG (mg/dL)

163.7 ± 9.2

162.7 ± 8.1

GA (%)

22.0 ± 0.8

21.2 ± 0.8

BNP (ng/mL) n = 21

429.2 ± 98.5

360.0 ± 79.3

hsCRP (mg/dL) n = 20

0.178 ± 0.046

0.193 ± 0.073

8OHdG (ng/mL) n = 12

0.356 ± 0.022

0.355 ± 0.041

  1. * P < 0.05 compared with before treatment
  2. Abbreviations are the same as shown for Table 2